Sign In
Get Clay Free →

Suggestions

    Kuni Itoh

    Astellas Pharma - Portfolio Strategy

    Kuni Itoh, a seasoned professional with a wealth of experience in healthcare and drug development programs evaluation, specializes in scientific, financial, and strategic assessments. This includes evaluating companies for M&A purposes, conducting due diligence, and formulating R&D strategies based on future scenario planning and capability analysis.

    With a strong background in CMC (Chemistry, Manufacturing, and Controls) research, Kuni has expertise in assay developments for biopharmaceutical characterization, release, and stability tests. Additionally, Kuni possesses skills in Design of Experience (DoE) software and basic statistics, and has managed activities at various CMO/CRO facilities worldwide. Kuni is well-versed in preparing regulatory dossiers for multiple countries including the US, EU, Canada, and Japan.

    Aside from practical experience, Kuni has also contributed to academia through publications and oral presentations. Their research work includes insightful studies on regenerative medicine guidelines and academic research papers in the field of regenerative medicines and cell therapies.

    Kuni Itoh's educational background is impressive, holding a PhD in the Department of Computational Biology and Medical Sciences from The University of Tokyo, an MS from the Division of Applied Life Sciences at Kyoto University, and a BS from the Department of Applied Life Sciences at Kyoto University. Kuni's career includes a senior management position at Astellas Pharma Inc. and past roles as a Senior Researcher at the same company and an Editorial Committee Member at the Japan Bioindustry Association.

    Kuni Itoh
    Add to my network

    Location

    Tokyo, Japan